How much dividend does Vifor Pharma pay?
Over the past 12 months, Vifor Pharma paid a dividend of 2 CHF . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Vifor Pharma is expected to pay a dividend of 6.28 CHF.
According to the latest status from December 2024, Vifor Pharma paid a total of 2.82 CHF per share in dividends within the last 12 months. With the current Vifor Pharma price of 166.15 CHF, this corresponds to a dividend yield of 1.7 %. A dividend is paid 1 times per year.
1.2 % Dividend Yield | = |
|
A dividend is paid 1 times per year. Last year, the payout months were and .
Paydate | Dividend |
---|---|
5/29/2022 | 2 |
6/10/2021 | 2 |
6/18/2020 | 2 |
6/10/2019 | 2 |
6/17/2018 | 2 |
6/16/2017 | 20 |
6/3/2016 | 18 |
6/12/2015 | 15 |
6/13/2014 | 14 |
6/6/2013 | 11 |
6/7/2012 | 9 |
6/9/2011 | 8 |
6/11/2010 | 7.5 |
6/19/2009 | 7 |
6/14/2008 | 6 |
6/30/2007 | 5 |
6/23/2006 | 4.3 |
9/15/2005 | 3.9 |
7/3/2004 | 3.6 |
6/28/2003 | 3.3 |
3 years
5 years
10 years
25 Years
Max
The dividend per year chart for Vifor Pharma provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Vifor Pharma’s potential for long-term investment and income generation through dividends.
Incorporate the dividend data in evaluating Vifor Pharma's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Date | Vifor Pharma Dividend |
---|---|
2026e | 7.47 undefined |
2025e | 6.28 undefined |
2024e | 3.77 undefined |
2023e | 2.82 undefined |
2022e | 2.57 undefined |
2021 | 2 undefined |
2020 | 2 undefined |
2019 | 2 undefined |
2018 | 2 undefined |
2017 | 2 undefined |
2016 | 1.8 undefined |
2015 | 1.5 undefined |
2014 | 1.4 undefined |
2013 | 1.1 undefined |
2012 | 0.9 undefined |
2011 | 0.8 undefined |
2010 | 0.75 undefined |
2009 | 0.7 undefined |
2008 | 0.6 undefined |
2007 | 0.5 undefined |
2006 | 0.43 undefined |
2005 | 0.39 undefined |
2004 | 0.36 undefined |
2003 | 0.33 undefined |
Dividend | Dividend (Estimate) | |
---|---|---|
2002 | 0 CHF | 0 CHF |
2003 | 0.33 CHF | 0 CHF |
2004 | 0.36 CHF | 0 CHF |
2005 | 0.39 CHF | 0 CHF |
2006 | 0.43 CHF | 0 CHF |
2007 | 0.5 CHF | 0 CHF |
2008 | 0.6 CHF | 0 CHF |
2009 | 0.7 CHF | 0 CHF |
2010 | 0.75 CHF | 0 CHF |
2011 | 0.8 CHF | 0 CHF |
2012 | 0.9 CHF | 0 CHF |
2013 | 1.1 CHF | 0 CHF |
2014 | 1.4 CHF | 0 CHF |
2015 | 1.5 CHF | 0 CHF |
2016 | 1.8 CHF | 0 CHF |
2017 | 2 CHF | 0 CHF |
2018 | 2 CHF | 0 CHF |
2019 | 2 CHF | 0 CHF |
2020 | 2 CHF | 0 CHF |
2021 | 2 CHF | 0 CHF |
2022e | 0 CHF | 2.57 CHF |
2023e | 0 CHF | 2.82 CHF |
2024e | 0 CHF | 3.77 CHF |
2025e | 0 CHF | 6.28 CHF |
2026e | 0 CHF | 7.47 CHF |
Vifor Pharma has been increasing the dividend for 1 years.
Over the past 10 years, Vifor Pharma has increased it by an annual 9.596 %.
Over a five-year period, the distribution increased by 2.13%.
Analysts expect a Dividend Increase of 13.32% for the current fiscal year.
3 years
5 years
10 years
25 Years
Max
The yearly payout ratio for Vifor Pharma represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
A lower payout ratio for Vifor Pharma could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Evaluate Vifor Pharma's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Date | Vifor Pharma Payout ratio |
---|---|
2026e | 69.98 % |
2025e | 69.83 % |
2024e | 74.89 % |
2023e | 65.23 % |
2022e | 69.36 % |
2021 | 90.09 % |
2020 | 36.23 % |
2019 | 81.77 % |
2018 | 85.32 % |
2017 | 11.33 % |
2016 | 49.32 % |
2015 | 32.34 % |
2014 | 31.93 % |
2013 | 24.12 % |
2012 | 23.08 % |
2011 | 23.26 % |
2010 | 21.19 % |
2009 | 21.6 % |
2008 | 20.62 % |
2007 | 24.27 % |
2006 | 27.04 % |
2005 | 31.45 % |
2004 | 30.25 % |
2003 | 32.04 % |
2002 | 69.36 % |
Payout ratio | |
---|---|
2002 | 69.36 % |
2003 | 32.04 % |
2004 | 30.25 % |
2005 | 31.45 % |
2006 | 27.04 % |
2007 | 24.27 % |
2008 | 20.62 % |
2009 | 21.6 % |
2010 | 21.19 % |
2011 | 23.26 % |
2012 | 23.08 % |
2013 | 24.12 % |
2014 | 31.93 % |
2015 | 32.34 % |
2016 | 49.32 % |
2017 | 11.33 % |
2018 | 85.32 % |
2019 | 81.77 % |
2020 | 36.23 % |
2021 | 90.09 % |
2022e | 69.36 % |
2023e | 65.23 % |
2024e | 74.89 % |
2025e | 69.83 % |
2026e | 69.98 % |
Vifor Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining Vifor Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Vifor Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in Vifor Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Over the past 12 months, Vifor Pharma paid a dividend of 2 CHF . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Vifor Pharma is expected to pay a dividend of 6.28 CHF.
The current dividend yield of Vifor Pharma is 1.2 %.
Vifor Pharma pays a quarterly dividend. This is distributed in the months of June, June, June, May.
Vifor Pharma paid dividends every year for the past 24 years.
For the upcoming 12 months, dividends amounting to 6.28 CHF are expected. This corresponds to a dividend yield of 3.78 %.
Vifor Pharma is assigned to the 'Health' sector.
To receive the latest dividend of Vifor Pharma from 5/3/2022 amounting to 2 CHF, you needed to have the stock in your portfolio before the ex-date on 4/29/2022.
The last dividend was paid out on 5/3/2022.
In the year 2023, Vifor Pharma distributed 2 CHF as dividends.
The dividends of Vifor Pharma are distributed in CHF.
Our stock analysis for Vifor Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vifor Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.